Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis
Annals of the Rheumatic Diseases · 2024
DOI: 10.1136/ard-2023-224878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2024. Verfasst von Fanlei Hu und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoimmune Diseases, B-Lymphocytes, Regulatory, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Peking University People’s Hospital, Basic and Applied Basic Research Foundation of Guangdong Province, Macau Science and Technology Development Fundation.
Abstract (Originalsprache)
OBJECTIVES: B10 and B10pro cells suppress immune responses via secreting interleukin (IL)-10. However, their regulators and underlying mechanisms, especially in human autoimmune diseases, are elusive. This study aimed to address these questions in rheumatoid arthritis (RA), one of the most common highly disabling autoimmune diseases. METHODS: The frequencies and functions of B10 and B10pro cells in healthy individuals and patients with RA were first analysed. The effects of proinflammatory cytokines, particularly tumour necrosis factor (TNF)-α on the quantity, stability and pathogenic phenotype of these cells, were then assessed in patients with RA before and after anti-TNF therapy. The underlying mechanisms were further investigated by scRNA-seq database reanalysis, transcriptome sequencing, TNF-α-/- and B cell-specific SHIP-1-/- mouse disease model studies. RESULTS: TNF-α was a key determinant for B10 cells. TNF-α elicited the proinflammatory feature of B10 and B10pro cells by downregulating IL-10, and upregulating interferon-γ and IL-17A. In patients with RA, B10 and B10pro cells were impaired with exacerbated proinflammatory phenotype, while anti-TNF therapy potently restored their frequencies and immunosuppressive functions, consistent with the increased B10 cells in TNF-α-/- mice. Mechanistically, TNF-α diminished B10 and B10pro cells by inhibiting their glycolysis and proliferation. TNF-α also regulated the phosphatidylinositol phosphate signalling of B10 and B10pro cells and dampened the expression of SHIP-1, a dominant phosphatidylinositol phosphatase regulator of these cells. CONCLUSIONS: TNF-α provoked the proinflammatory phenotype of B10 and B10pro cells by disturbing SHIP-1 in RA, contributing to the disease development. Reinstating the immunosuppressive property of B10 and B10pro cells might represent novel therapeutic approaches for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China fanleihu@bjmu.edu.cn LiuLab@tsinghua.edu.cn…
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
- Department of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing, China.
- State Key Laboratory of Membrane Biology, China Ministry of Education Key Laboratory of Protein Sciences, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology…
- Peking-Tsinghua Center for Life Sciences, Beijing, China.
Förderung
- Peking University People’s Hospital
- Basic and Applied Basic Research Foundation of Guangdong Province
- Macau Science and Technology Development Fundation
- Beijing Nova Program
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Peking University
Zitieren
APA
Hu, F., Shi, L., Liu, X., Chen, Y., Zhang, X., Jia, Y., Liu, X., Guo, J., Zhu, H., Liu, H., Xu, L., Li, Y., Wang, P., Fang, X., Xue, J., Xie, Y., Wei, C., Song, J., Zheng, X., …, & Li, Z. (2024). Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2023-224878
Vancouver
Hu F, Shi L, Liu X, Chen Y, Zhang X, Jia Y, et al. Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2024. doi:10.1136/ard-2023-224878
BibTeX
@article{Hu2024,
author = {Hu, Fanlei and Shi, Lianjie and Liu, Xiaohang and Chen, Yingjia and Zhang, Xia and Jia, Yuan and Liu, Xu and Guo, Jianping and Zhu, Huaqun and Liu, Hongjiang and Xu, Liling and Li, Yingni and Wang, Ping and Fang, Xiangyu and Xue, Jimeng and Xie, Yang and Wei, Chaonan and Song, Jing and Zheng, Xi and Liu, Yan-Ying and Li, Yuhui and Ren, Limin and Xu, Dakang and Lu, Liwei and Qiu, Xiaoyan and Mu, Rong and He, Jing and Wang, Min and Zhang, Xuan and Liu, Wanli and Li, Zhanguo},
title = {Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2024},
doi = {10.1136/ard-2023-224878}
}
EUVIMED